Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1
Daniel Rubins, Xiangjun Meng, Paul McQuade, et al.
Molecular Imaging and Biology (2020) Vol. 23, Iss. 2, pp. 241-249
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
Leona Rašková Kafková, Joanna Maria Mierzwicka, Prosenjit Chakraborty, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Quantifying PD-L1 Expression to Monitor Immune Checkpoint Therapy: Opportunities and Challenges
Sridhar Nimmagadda
Cancers (2020) Vol. 12, Iss. 11, pp. 3173-3173
Open Access | Times Cited: 50
Radiochemistry with {Al18F}2+: Current status and optimization perspectives for efficient radiofluorination by complexation
Sébastien Schmitt, Emmanuel Moreau
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215028-215028
Open Access | Times Cited: 19
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
Fabian Krutzek, Cornelius K. Donat, Martin Ullrich, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2638-2638
Open Access | Times Cited: 19
Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy
Yuanfeng Zhang, Juanjuan Wu, Chaobin Zhao, et al.
Journal of Cancer (2023) Vol. 14, Iss. 5, pp. 850-873
Open Access | Times Cited: 16
Integrating Dynamic Network Analysis with AI for Enhanced Epitope Prediction in PD-L1:Affibody Interactions
Diego E. B. Gomes, Byeongseon Yang, Rosario Vanella, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 34, pp. 23842-23853
Open Access | Times Cited: 7
The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers
Virginia Liberini, Riccardo Laudicella, Martina Capozza, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2201-2201
Open Access | Times Cited: 36
Development of Radiotracers for Imaging of the PD-1/PD-L1 Axis
Fabian Krutzek, Klaus Kopka, Sven Stadlbauer
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 747-747
Open Access | Times Cited: 25
ImmunoPET Imaging of Immune Checkpoints to Assess Their Cancer Therapeutic Potential
Coral Wynter, Navya Murugesan, Arutselvan Natarajan
(2025), pp. 1-34
Closed Access
Synthesis and preclinical evaluation of an Al18F radio-fluorinated bivalent PD-L1 nanobody
Yong Huang, Dongye Zheng, Chengze Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117487-117487
Closed Access
Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
Gitanjali Sharma, Marta Braga, Chiara Da Pieve, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3131-3131
Open Access | Times Cited: 10
An overview of current advances of PD-L1 targeting immuno-imaging in cancers
Yunhao Chen, Yujiao Guo, Zhiguo Liu, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 4, pp. 866-875
Open Access | Times Cited: 10
Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities
Melinda Badenhorst, Albert D. Windhorst, Wissam Beaino
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Directed Evolution of PD-L1-Targeted Affibodies by mRNA Display
Brian J. Grindel, Brian J. Engel, Justin N. Ong, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 6, pp. 1543-1555
Open Access | Times Cited: 13
Noninvasive Imaging of Tumor PD-L1 Expression Using [99mTc]Tc-Labeled KN035 with SPECT/CT
Yingying Zhang, Ying Ding, Ning Li, et al.
Molecular Pharmaceutics (2022) Vol. 20, Iss. 1, pp. 690-700
Closed Access | Times Cited: 13
Aptamer-Based Immunotheranostic Strategies
María Fernanda García Melián, María Moreno, Hugo Cerecetto, et al.
Cancer Biotherapy and Radiopharmaceuticals (2023) Vol. 38, Iss. 4, pp. 246-255
Closed Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Small-Molecule-Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1
Fabian Krutzek, Cornelius K. Donat, Martin Ullrich, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 15894-15915
Open Access | Times Cited: 6
The role of PET molecular imaging in immune checkpoint inhibitor therapy in lung cancer: Precision medicine and visual monitoring
Yuan Yao, Xin Zhou, Annan Zhang, et al.
European Journal of Radiology (2022) Vol. 149, pp. 110200-110200
Closed Access | Times Cited: 9
Molecular imaging of immune checkpoints in oncology: Current and future applications
Shushan Ge, Tongtong Jia, Jihui Li, et al.
Cancer Letters (2022) Vol. 548, pp. 215896-215896
Closed Access | Times Cited: 9
Novel small 99mTc-labeled affibody molecular probe for PD-L1 receptor imaging
Zhigang Liang, Xianwen Hu, Hongyu Hu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Evaluation of 89Zr-Labeled Anti-PD-L1 Monoclonal Antibodies Using DFO and Novel HOPO Analogues as Chelating Agents for Immuno-PET
Bhasker Radaram, Sarah Glazer, Ping Yang, et al.
ACS Omega (2023) Vol. 8, Iss. 19, pp. 17181-17194
Open Access | Times Cited: 4
Dose escalation biodistribution, positron emission tomography/computed tomography imaging and dosimetry of a highly specific radionuclide-labeled non-blocking nanobody
Yanling Yang, Chao Wang, Yan Wang, et al.
EJNMMI Research (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Immune checkpoint inhibition: a future guided by radiology
Faraaz Khan, Keaton Jones, Paul Lyon
British Journal of Radiology (2023)
Open Access | Times Cited: 2
Application of molecular imaging in immune checkpoints therapy: From response assessment to prognosis prediction
Wan‐Ling Liu, Yong‐Qu Zhang, Liangtao Li, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103746-103746
Closed Access | Times Cited: 4
Engineering the Mechanical Stability of a Therapeutic Affibody/PD-L1 Complex by Anchor Point Selection
Byeongseon Yang, Diego E. B. Gomes, Zhaowei Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top